RxDoctor Payments Data

Christina Rust, PA

Physician Assistant · Sandpoint, IDNPI 1780731786

Payments from drug & device makers

$994in general payments, 2019–2025

Across 59 payments — averaging $16.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kowa Pharmaceuticals America, Inc.$238
  • Amgen$173
  • Boehringer Ingelheim$120
  • Novo Nordisk$95
  • Mylan Specialty L.p.$78
  • AbbVie$71
  • plus $218 from 9 others

What the payments were for

  • Food & beverage$994100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$994 in reported general payments places this provider in the 70th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho

Medicare billing

Part B allowed, 2024
$119,293
Medicare patients
233
Services billed
2,586

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide24$33,990
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$26,027
EliquisApixaban24$26,011
RybelsusSemaglutide18$16,315
JardianceEmpagliflozin21$15,576
Breztri AerosphereBudesonide/Glycopyr/Formoterol20$11,628
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr18$10,115
SuboxoneBuprenorphine Hcl/Naloxone Hcl13$9,026
Spiriva RespimatTiotropium Bromide16$8,014
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl45$6,737
Desvenlafaxine Succinate ErDesvenlafaxine Succinate23$3,295
Atorvastatin Calcium203$2,698
Hydroxychloroquine Sulfate35$2,666
Albuterol Sulfate HfaAlbuterol Sulfate106$2,634
Buprenorphine Hcl48$2,558

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$95$50,30542 claims
GSKTrelegy Ellipta, Anoro Ellipta$16$36,14258 claims
PfizerEliquis$17$26,01124 claims
Boehringer IngelheimJardiance, Spiriva Respimat$120$23,59137 claims
AstraZenecaBreztri Aerosphere$15$11,62820 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,027 physician assistant providers in Idaho.

Other physician assistant in Sandpoint

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →